Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Casopitant for Prevention of CINV
NCT00104403Phase 2Completed
- Sponsor
- GSK
- Start
- Dec 2004
- Primary completion
- Jan 2006
- Modality
- Small Molecules
- Countries
- 24
01
Overview
A Phase 2 trial of casopitant in chemotherapy-induced nausea and vomiting (CINV), sponsored by GSK. Started Dec 2004; status: completed.
02
Drugs
casopitant
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT00104403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00104403.